CAHR's NATIONAL DAY

NATIONAL DAY 

Battening Down the Healthcare Hatches: Making the Case for Patient Access in a Time of Fiscal and Trade Upheaval

WEDNESDAY, DECEMBER 3, 2025 |  9:00 AM - 5:00 PM (ET)
DELTA HOTELS OTTAWA CITY CENTRE
101 LYONS STREET NORTH, OTTAWA

Take advantage of the special rate of $237/night at the Delta Hotel Ottawa City Centre!  Be sure to book your room by Wednesday, November 5, 2025, to lock in this exclusive offer. To make your reservation, [click here].

Highlighted by the ever-popular pundits panel, the CAHR National Day planning committee invites you to join us in Ottawa for an insightful day of analysis and discussion about how Canadian health care leaders are coping in uncertain times to ensure patient access to needed treatments and services. We will consider the fiscal scene and reflect on the oft-changing global trade situation and explore their impact on health care. In addition, we will bring you perspectives from pharmaceutical policy experts addressing the key files, including national pharmacare, rare disease, pricing and access. We look forward to seeing you in the nation’s capital!

Important Notice: Please be advised that the program agenda is currently in draft form and may be subject to revisions. We encourage you to monitor your email regularly or visit the website for program updates.

AGENDA
(As of October 2, 2025)

9am  Welcome & Housekeeping
Emcee: Bill Dempster, 3Sixty Public Affairs

9:05am
Keynote: The Impact of the Fiscal Situation on Healthcare

9:50am
Panel: Assessing the Impact of Trade Upheaval in the Canadian Market     
In the midst of ongoing trade and tariff uncertainty, the Canadian life sciences community is seeking clarity and insights to help them manage. This panel will provide an update on the current state of tariff negotiations with the US and preparation for the CUSMA negotiations. It will also offer perspectives on the state of affairs from the global pharmaceutical industry, the pharmacy community and a patient leader.

William Pellerin, McMillan LLC
Dr. Shelita Dattani, Neighbourhood Pharmacy Association of Canada
Moderator: Steve Sampson, Global Public Affairs

10:35am  Networking Break

11:00am
Panel: What’s Next for Federal & National Pharmacare and Rare Disease Policy  
A change in leadership in Ottawa and a dynamic political and trade environment have raised questions about the future for two important federal policy initiatives. This panel will explore the current state of the efforts and consider where the political winds might take us.

Rosalie Wyonch, CD Howe Institute
Marcel Saulnier, Santis Health
Moderator: Fred Horne, 3Sixty Public Affairs

12:00nn Lunch Break

1:00pm
TED Talk 

1:30pm
PMPRB Guidelines & Five-year Strategic Plan
We are pleased to welcome the Patented Medicine Prices Review Board chair Anie Perrault to discuss the upcoming launch of the agency’s new price review guidelines that staff will rely upon in pursuing its mandate to ensure Canadian prices for patented medicines are non-excessive. She will also outline her vision for the board’s next phase. Perrault’s comments will be followed by a response from IQVIA’ s Canadian pharmaceutical pricing leader, Joan McCormick.

Anie Perrault, PMPRB
Joan McCormick, IQVIA
Moderator: Bill Dempster, 3Sixty Public Affairs

2:15pm 
Bear Pit Session with CEOs from CDA and pCPA
Following a talk show format, Gerry Jeffcott will lead McGurn and Chies through a moderated discussion about the latest developments within their respective agencies and the evolution of pharmaceutical review and reimbursement policy in Canada. Audience members will be invited to ask their questions as well in this interactive session.

Suzanne McGurn, President & CEO, CDA
Mauro Chies, pCPA CEO
Moderator: Gerry Jeffcott, 3Sixty Public Affairs

3:15pm Networking Break

3:45pm
Political Roundtable – Pundit Panel 

Moderator: Hannah Thibodeau, Global Public Affairs

4:30pm Closing Remarks
Emcee: Bill Dempster, 3Sixty Public Affairs

THANK YOU TO ALL OUR SPONSORS

GOLD

SILVER

BRONZE